Joseph Edelman – ASND history
- Issuer:
- ASCENDIS PHARMA A/S
- Quarters tracked:
- 13 (Q1 2018 → Q1 2026)
- Current shares:
- 1,531,421
- Current value:
- $350.28M
- Peak shares:
- 1,531,421 (Q1 2026)
- Overall change:
- +56%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 1,531,421 | $350.28M | $228.73 | +450,000 | +42% |
| Q4 2025 | 1,081,421 | $230.60M | $213.24 | -7,080 | -1% |
| Q3 2025 | 1,088,501 | $216.41M | $198.81 | +124,615 | +13% |
| Q2 2025 | 963,886 | $166.37M | $172.60 | +963,886 | +100% |
| Q1 2024 | SOLD | — | — | -132,176 | -100% |
| Q4 2023 | 132,176 | $16.65M | $125.95 | +132,176 | +100% |
| Q3 2019 | SOLD | — | — | -473,475 | -100% |
| Q2 2019 | 473,475 | $54.52M | $115.15 | -639,853 | -57% |
| Q1 2019 | 1,113,328 | $131.04M | $117.70 | +60,681 | +6% |
| Q4 2018 | 1,052,647 | $63.04M | $59.89 | -20,000 | -2% |
| Q3 2018 | 1,072,647 | $76.01M | $70.86 | 0 | 0% |
| Q2 2018 | 1,072,647 | $71.35M | $66.52 | +90,000 | +9% |
| Q1 2018 | 982,647 | $64.27M | $65.40 | — | NEW |